Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Zammit

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAndrew K McVea, Max McLachlan, Brecca Bettcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAndrew K McVea, Max McLachlan, Brecca Bettcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand <sup>18</sup>F-MK-6240 in Humans from Alzheimer Disease Dementia to Young ControlsTobey J Betthauser, Karly A Cody, Matthew D Zammit, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 30, 2020
Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndromeSigan L Hartley, Benjamin L Handen, Darlynne Devenny, et al.
Neurobiology of Aging|May 25, 2020
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndromeKarly A Cody, Brianna Piro-Gambetti, Matthew D Zammit, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|August 13, 2025
Lifestyle Composite and Resilience to Alzheimer's Disease Pathology in Down SyndromeEmily K Schworer, Matthew D Zammit, Benjamin L Handen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsCourtney Brothers, Julie K Wisch, Benjamin L Handen, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAndrew K McVea, Max McLachlan, Brecca Bettcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAndrew K McVea, Max McLachlan, Brecca Bettcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand <sup>18</sup>F-MK-6240 in Humans from Alzheimer Disease Dementia to Young ControlsTobey J Betthauser, Karly A Cody, Matthew D Zammit, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 30, 2020
Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndromeSigan L Hartley, Benjamin L Handen, Darlynne Devenny, et al.
Neurobiology of Aging|May 25, 2020
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndromeKarly A Cody, Brianna Piro-Gambetti, Matthew D Zammit, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|August 13, 2025
Lifestyle Composite and Resilience to Alzheimer's Disease Pathology in Down SyndromeEmily K Schworer, Matthew D Zammit, Benjamin L Handen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsCourtney Brothers, Julie K Wisch, Benjamin L Handen, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Pageof 3